179 related articles for article (PubMed ID: 33036558)
1. Risk factors associated with infection of blood-borne virus among people who used methamphetamine.
Cai Y; Dai Z; Wen S; Bhandari R
BMC Infect Dis; 2020 Oct; 20(1):742. PubMed ID: 33036558
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
3. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
[TBL] [Abstract][Full Text] [Related]
4. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
Altawalah H; Essa S; Ezzikouri S; Al-Nakib W
Sci Rep; 2019 Apr; 9(1):6292. PubMed ID: 31000775
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study.
Calin R; Massari V; Pialoux G; Reydellet N; Plenel E; Chauvin C; Jauffret-Roustide M; Day N; Kreplak G; Maresca AF; Derche N; Louis S; Pol S; Doré V; Rouzioux C; Chauvin P
BMC Infect Dis; 2020 Nov; 20(1):851. PubMed ID: 33198672
[TBL] [Abstract][Full Text] [Related]
11. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
12. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
14. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
Alipour A; Haghdoost AA; Sajadi L; Zolala F
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
16. Sexual behaviors and seroprevalence of HIV, HBV, and HCV among hill tribe youths of Northern Thailand.
Apidechkul T
BMC Public Health; 2019 Aug; 19(1):1101. PubMed ID: 31412838
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
Pereson MJ; Martínez AP; Isaac K; Laham G; Ridruejo E; Garcia GH; Flichman DM; Di Lello FA
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33180017
[No Abstract] [Full Text] [Related]
18. Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain.
Toro C; Jiménez V; Rodríguez C; Del Romero J; Rodés B; Holguín A; Alvarez P; García-Campello M; Gómez-Hernando C; Guelar A; Sheldon J; de Mendoza C; Simón A; Soriano V
J Med Virol; 2006 Dec; 78(12):1599-608. PubMed ID: 17063510
[TBL] [Abstract][Full Text] [Related]
19. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.
Hope VD; Harris R; McVeigh J; Cullen KJ; Smith J; Parry JV; DeAngelis D; Ncube F
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):331-7. PubMed ID: 26361173
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]